Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 61 - 70 of 1441 shown below

  • Gakiopoulou, H

    H Gakiopoulou, P Korkolopoulou, G Levidou, I Thymara, A Saetta, C Piperi, N Givalos, I Vassilopoulos, K Ventouri, A Tsenga, A Bamias, M-A Dimopoulos, E Agapitos and E Patsouris

    Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications

    advance online publication, 2007-10-16 00:00:00.000;

    doi:10.1038/sj.bjc.6603992

  • Gakwaya, A

    A Gakwaya, J B Kigula-Mugambe, A Kavuma, A Luwaga, J Fualal, J Jombwe, M Galukande and D Kanyike

    Cancer of the breast: 5-year survival in a tertiary hospital in Uganda

    advance online publication, 2008-06-24 00:00:00.000;

    doi:10.1038/sj.bjc.6604435

  • Gal, I

    M Koren, G Kimmel, E Ben-Asher, I Gal, M Z Papa, J S Beckmann, D Lancet, R Shamir and E Friedman

    ATM haplotypes and breast cancer risk in Jewish high-risk women

    advance online publication, 2006-04-04 00:00:00.000;

    doi:10.1038/sj.bjc.6603062

  • Galán, A

    J Feliu, A Salud, P Escudero, L Lopez-Gómez, M Bolaños, A Galán, J-M Vicent, A Yubero, F Losa, J De Castro, M Á de Mon, E Casado and M González-Barón

    XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

    advance online publication, 2006-03-21 00:00:00.000;

    doi:10.1038/sj.bjc.6603047

  • Gala, J-L

    P Eschwège, S Moutereau, S Droupy, R Douard, J-L Gala, G Benoit, M Conti, P Manivet and S Loric

    Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study

    doi:10.1038/sj.bjc.6604912

  • Galais, M P

    P Michel, A Adenis, F Di Fiore, E Boucher, M P Galais, L Dahan, X Mirabel, H Hamidou, J L Raoul, J H Jacob, M F Hellot, S Prod'Homme and B Paillot

    Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

    doi:10.1038/sj.bjc.6603328

  • F Di Fiore, F Blanchard, F Charbonnier, F Le Pessot, A Lamy, M P Galais, L Bastit, A Killian, R Sesboüé, J J Tuech, A M Queuniet, B Paillot, J C Sabourin, F Michot, P Michel and T Frebourg

    Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

    advance online publication, 2007-03-20 00:00:00.000;

    doi:10.1038/sj.bjc.6603685

  • Galakhin, K

    B Franc, M Valenty, K Galakhin, E Kovalchuk, V Kulagenko, A Puchkou, Y Sidorov and M Tirmarche

    Histological validation of diagnoses of thyroid cancer among adults in the registries of Belarus and the Ukraine

    doi:10.1038/sj.bjc.6601395

  • Galanis, E

    E Galanis and J Buckner

    Chemotherapy for high-grade gliomas

    doi:10.1054/bjoc.1999.1075

  • E Galanis and S Russell

    Cancer gene therapy clinical trials: lessons for the future

    doi:10.1054/bjoc.2001.2129

  • Galanski, M

    T F Greten, F Papendorf, J S Bleck, T Kirchhoff, T Wohlberedt, S Kubicka, J Klempnauer, M Galanski and M P Manns

    Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients

    advance online publication, 2005-05-03 00:00:00.000;

    doi:10.1038/sj.bjc.6602590

  • Galateau-Sallé, F

    P Ruffié, M Lehmann, F Galateau-Sallé, J L Lagrange and J C Pairon

    Malignant mesothelioma

    doi:10.1054/bjoc.2001.1763